Jesús María
Hernández Rivas
Catedrático de Universidad
Hospital Infantil Universitario Niño Jesus de Madrid
Madrid, EspañaPublications en collaboration avec des chercheurs de Hospital Infantil Universitario Niño Jesus de Madrid (6)
2022
-
Clonal heterogeneity and rates of specific chromosome gains are risk predictors in childhood high-hyperdiploid B-cell acute lymphoblastic leukemia
Molecular Oncology, Vol. 16, Núm. 16, pp. 2899-2919
2021
-
CRISPR-Cas9 Technology as a Tool to Target Gene Drivers in Cancer: Proof of Concept and New Opportunities to Treat Chronic Myeloid Leukemia
CRISPR Journal, Vol. 4, Núm. 4, pp. 519-535
2020
-
Helpful criteria when implementing ngs panels in childhood lymphoblastic leukemia
Journal of Personalized Medicine, Vol. 10, Núm. 4, pp. 1-15
2019
-
Splice donor site sgRNAs enhance CRISPR/ Cas9-mediated knockout efficiency
PLoS ONE, Vol. 14, Núm. 5
2017
-
Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia
British Journal of Cancer, Vol. 117, Núm. 2, pp. 256-265
2014
-
Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm
Leukemia, Vol. 28, Núm. 4, pp. 823-829